SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Asset Advisors Investment Management LLC

Asset Advisors Investment Management LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,890 shares of the exchange traded fund’s stock after selling 225 shares during the quarter. Asset Advisors Investment Management LLC’s holdings in SPDR S&P Biotech ETF were worth $449,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. WP Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 13.5% during the 3rd quarter. WP Advisors LLC now owns 6,598 shares of the exchange traded fund’s stock worth $503,000 after acquiring an additional 786 shares during the last quarter. BTR Capital Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 0.4% during the 3rd quarter. BTR Capital Management Inc. now owns 97,677 shares of the exchange traded fund’s stock worth $7,448,000 after acquiring an additional 381 shares during the last quarter. Whittier Trust Co. lifted its stake in shares of SPDR S&P Biotech ETF by 0.7% during the 3rd quarter. Whittier Trust Co. now owns 202,074 shares of the exchange traded fund’s stock worth $15,408,000 after acquiring an additional 1,486 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 11.2% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 46,572 shares of the exchange traded fund’s stock worth $3,551,000 after acquiring an additional 4,698 shares during the last quarter. Finally, Coastal Investment Advisors Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 14.5% during the 3rd quarter. Coastal Investment Advisors Inc. now owns 3,711 shares of the exchange traded fund’s stock worth $286,000 after acquiring an additional 470 shares during the last quarter.

XBI opened at $80.43 on Thursday. The stock’s fifty day moving average is $79.15 and its two-hundred day moving average is $83.26. SPDR S&P Biotech ETF has a 52 week low of $64.38 and a 52 week high of $93.87.

The company also recently disclosed a — dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 23rd were paid a dividend of $0.0032 per share. The ex-dividend date of this dividend was Friday, September 20th. This represents a yield of 0.1%.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: How does the Federal Reserve determine interest rates?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.